0001127602-25-014718.txt : 20250516 0001127602-25-014718.hdr.sgml : 20250516 20250516163429 ACCESSION NUMBER: 0001127602-25-014718 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250515 FILED AS OF DATE: 20250516 DATE AS OF CHANGE: 20250516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dickinson Andrew D CENTRAL INDEX KEY: 0001310204 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 25959852 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2025-05-15 0000882095 GILEAD SCIENCES, INC. GILD 0001310204 Dickinson Andrew D GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Chief Financial Officer 1 Common Stock 2025-05-15 4 S 0 2500 99.82 D 165674 D The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson 2025-05-16